Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia

Mayo Clinic Proceedings

Volumn 89, Issue 1, 2014, Pages 60-68

  Corrales Medina, Vicente F ^a,c   Taljaard, Monica ^b,c   Fine, Michael J ^e   Dwivedi, Girish ^a,d   Perry, Jeffrey J ^b,c   Musher, Daniel M ^f   Chirinos, Julio A ^g  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Department of Epidemiology and Community Medicine ^*  (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE; ARTERIAL PH; ARTICLE; CARDIOVASCULAR RISK; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART FAILURE; HEMATOCRIT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMONIA SEVERITY INDEX; PREDICTION; PROSPECTIVE STUDY; PULSE RATE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS;

EID: 84893048965     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.09.015     Document Type: Article

References (25)

1. File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122(2):130-141.
2. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71-79.
3. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with communityacquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125(6):773-781.
4. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013;381(9865):496-505.
5. Viasus D, Garcia-Vidal C, Manresa F, Dorca J, Gudiol F, Carratalà J. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect. 2013;66(1):27-33.
6. Aujesky D, Fine MJ. The pneumonia severity index: a decade after the initial derivation and validation. Clin Infect Dis. 2008; 47(suppl 3):S133-S139.
7. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis. 2008;47(2):182-187.
8. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1999;159(9):970-980.
9. Fine MJ, Stone RA, Lave JR, et al. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial. Am J Med. 2003;115(5):343-351.
10. Corrales-Medina VF, Suh KN, Rose G, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011;8(6):e1001048.
11. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-829.
13. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study [published correction appears in JAMA. 1994;271(17):1321]. JAMA. 1993;270(24):2957-2963.
14. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250.
15. Lambert J, Lipkovich I. A macro for getting more out of your ROC curve. In: Proceedings of the SAS Global Forum 2008. Cary, NC: SAS Institute Inc; 2008:Paper 231-2008. http://www2.sas.com/proceedings/forum2008/231-2008.pdf. Accessed March 30, 2013.
16. Sarle WS. The VARCLUS procedure. In: SAS/STAT User's Guide. 4th ed., Vol 2. Cary, NC: SAS Institute Inc; 1990:1641-1659.
17. Grønnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal. 1996;2(4):315-328.
18. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4):361-387.
19. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19(8):1059-1079.
20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172.
21. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176(6):473-481.
22. Kennedy KF, Pencina MJ. A SAS macro to compute added predictive ability of new markers predicting a dichotomous outcome. http://analytics.ncsu.edu/ sesug/2010/SDA07.Kennedy. pdf. Accessed March 30 2013
23. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
24. Flanders WD, Tucker G, Krishnadasan A, Martin D, Honig E, McClellan WM. Validation of the pneumonia severity index: importance of study-specific recalibration. J Gen Intern Med. 1999;14(6):333-340.
25. Thomsen TF, McGee D, Davidsen M, Jørgensen T. A crossvalidation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol. 2002;31(4): 817-822.